Omega Therapeutics, Inc.
OMGA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $68 | $71 | $186 | $23 |
| Short-Term Investments | $5 | $0 | $39 | $0 |
| Receivables | $7 | $2 | $1 | $0 |
| Inventory | $0 | $41 | $0 | $0 |
| Other Curr. Assets | $9 | $11 | $3 | $1 |
| Total Curr. Assets | $90 | $125 | $229 | $24 |
| Property Plant & Equip (Net) | $114 | $8 | $4 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $13 | $0 | $0 |
| Total NC Assets | $114 | $21 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $204 | $146 | $233 | $28 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $1 |
| Short-Term Debt | $15 | $6 | $0 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $3 |
| Other Curr. Liab. | $10 | $12 | $10 | $4 |
| Total Curr. Liab. | $27 | $22 | $12 | $8 |
| LT Debt | $113 | $18 | $20 | $9 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $0 | $1 | $76 |
| Total NC Liab. | $120 | $18 | $21 | $85 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $110 | $3 | $0 | $0 |
| Total Liabilities | $146 | $40 | $33 | $93 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $75 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$335 | -$237 | -$135 | -$66 |
| AOCI | -$0 | -$0 | -$0 | -$75 |
| Other Equity | $393 | $344 | $335 | $150 |
| Total Equity | $58 | $106 | $201 | -$65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $204 | $146 | $233 | $28 |
| Net Debt | $60 | -$47 | -$167 | -$11 |